These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3004634)

  • 41. Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG.
    Klasse J; Blomberg J
    J Infect Dis; 1987 Dec; 156(6):1026-30. PubMed ID: 3479499
    [No Abstract]   [Full Text] [Related]  

  • 42. HTLV-III and the etiology of AIDS.
    Gallo RC; Sarngadharan MG; Popovic M; Shaw GM; Hahn B; Wong-Staal F; Robert-Guroff M; Zaki Salahuddin S; Markham PD
    Prog Allergy; 1986; 37():1-45. PubMed ID: 3008160
    [No Abstract]   [Full Text] [Related]  

  • 43. Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals.
    Steimer KS; Higgins KW; Powers MA; Stephans JC; Gyenes A; George-Nascimento C; Luciw PA; Barr PJ; Hallewell RA; Sanchez-Pescador R
    J Virol; 1986 Apr; 58(1):9-16. PubMed ID: 2419593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 48. Relation of HTLV-III seropositivity and lymphadenopathy.
    Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
    Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
    Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
    J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphadenopathy-associated virus: from molecular biology to pathogenicity.
    Montagnier L
    Ann Intern Med; 1985 Nov; 103(5):689-93. PubMed ID: 2996400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
    Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
    Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.
    Ohta M; Ohta K; Mori F; Nishitani H; Saida T
    J Immunol; 1986 Dec; 137(11):3440-3. PubMed ID: 3023483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
    Klasse PJ; Pipkorn R; Blomberg J
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.
    Wang JJ; Steel S; Wisniewolski R; Wang CY
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera.
    Kanki PJ; Kurth R; Becker W; Dreesman G; McLane MF; Essex M
    Lancet; 1985 Jun; 1(8441):1330-2. PubMed ID: 2860515
    [No Abstract]   [Full Text] [Related]  

  • 56. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.
    Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC
    JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.
    Veronese FD; DeVico AL; Copeland TD; Oroszlan S; Gallo RC; Sarngadharan MG
    Science; 1985 Sep; 229(4720):1402-5. PubMed ID: 2994223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphadenopathy associated virus (L.A.V.): its association with AIDS or prodromes.
    Barré-Sinoussi F; Chermann JC
    Adv Exp Med Biol; 1985; 187():35-43. PubMed ID: 2994418
    [No Abstract]   [Full Text] [Related]  

  • 59. Genomic variability of selected LAV-related AIDS retroviruses.
    Magasiny S; Spire B; Barré-Sinoussi F; Chermann JC
    AIDS Res; 1986 Feb; 2(1):19-30. PubMed ID: 2424466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro.
    Aldovini A; Debouck C; Feinberg MB; Rosenberg M; Arya SK; Wong-Staal F
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6672-6. PubMed ID: 3018743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.